: FDA approves Victoza (liraglutide) injection for pediatric patients with type 2 diabetes. Victoza creates the same effect as GLP-1 receptor protein and is the first non-insulin drug approved since metformin in 2000.
from FDA Press Releases RSS Feed http://bit.ly/2IlIIuw
via IFTTT
No comments:
Post a Comment